Skip to content
10-K

Annual Report

AXSOME THERAPEUTICS, INC. AXSM

0001193125-26-064267

← back to feed
Filed
Feb 23, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 16, 2026 51.15M sh
Shares Diluted FY 2025 · Dec 31, 2025 49.75M sh
Shares Diluted FY 2025 · Dec 31, 2024 47.91M sh
Shares Diluted FY 2025 · Dec 31, 2023 45.43M sh
Capex FY 2025 · Dec 31, 2025 $480K
Capex FY 2025 · Dec 31, 2024 $270K
Capex FY 2025 · Dec 31, 2023 $582K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$93.41M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$128.41M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$145.08M
Long Term Debt FY 2025 · Dec 31, 2025 $117.75M
Long Term Debt FY 2025 · Dec 31, 2024 $180.71M
Short Term Debt FY 2025 · Dec 31, 2025 $70M
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $322.93M
Cash And Equivalents FY 2025 · Dec 31, 2024 $315.35M
Stockholders Equity FY 2025 · Dec 31, 2025 $88.3M
Stockholders Equity FY 2025 · Dec 31, 2024 $57.02M
Stockholders Equity FY 2025 · Dec 31, 2023 $190.98M
Stockholders Equity restated FY 2025 · Dec 31, 2022 $109.56M
Current Liabilities FY 2025 · Dec 31, 2025 $378.84M
Current Liabilities FY 2025 · Dec 31, 2024 $230.1M
Total Liabilities FY 2025 · Dec 31, 2025 $601.51M
Total Liabilities FY 2025 · Dec 31, 2024 $511.48M
Current Assets FY 2025 · Dec 31, 2025 $588.99M
Current Assets FY 2025 · Dec 31, 2024 $485.06M
Total Assets FY 2025 · Dec 31, 2025 $689.81M
Total Assets FY 2025 · Dec 31, 2024 $568.5M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.68
Eps Diluted FY 2025 · Dec 31, 2024 −$5.99
Eps Diluted FY 2025 · Dec 31, 2023 −$5.27
Eps Basic FY 2025 · Dec 31, 2025 −$3.68
Eps Basic FY 2025 · Dec 31, 2024 −$5.99
Eps Basic FY 2025 · Dec 31, 2023 −$5.27
Sga Expense FY 2025 · Dec 31, 2025 $570.6M
Sga Expense FY 2025 · Dec 31, 2024 $411.36M
Sga Expense FY 2025 · Dec 31, 2023 $323.12M
Rd Expense FY 2025 · Dec 31, 2025 $183.28M
Rd Expense FY 2025 · Dec 31, 2024 $187.08M
Rd Expense FY 2025 · Dec 31, 2023 $97.94M
Net Income FY 2025 · Dec 31, 2025 −$183.17M
Net Income FY 2025 · Dec 31, 2024 −$287.22M
Net Income FY 2025 · Dec 31, 2023 −$239.24M
Operating Income FY 2025 · Dec 31, 2025 −$166.76M
Operating Income FY 2025 · Dec 31, 2024 −$280.56M
Operating Income FY 2025 · Dec 31, 2023 −$231.83M
Revenue FY 2025 · Dec 31, 2025 $638.5M
Revenue FY 2025 · Dec 31, 2024 $385.69M
Revenue FY 2025 · Dec 31, 2023 $270.6M